🇮🇳 Real-world data from >1000 patients with MASLD/MetALD
MRI-PDFF phenotyping + 🧲 MRE anchor
🔍 Key takeaways:
✔️ Similar CMRF & AF burden
✔️ FIB-4 & NFS perform well
❌ APRI underperforms
💡 Simple NITs even for MetALD
@AnandVKulkarni2@DrMaheshgoenka
https://t.co/4o4nXkFJ5e
🧵NEW STUDY PUBLISHED
Our DiaFib-Liver Study is now published in @LancetRH_SEAsia.
The largest-ever real-world survey of liver fibrosis in type 2 diabetes from any low- or middle-income country.
9,202 patients. 82 doctors. Pan-India. 🇮🇳
🔗 https://t.co/DPVtTIMifK
#Fibrosis prevalence across clinical subgroups:
Highest: CAD (33%),
eGFR <60 (33%),
Obesity (32%),
Dyslipidaemia (30%)
Even without obesity: 19%
Dashed line = overall prevalence (26%).
No difference by sex or hypothyroidism.
Fibrosis is widespread across ALL subgroups.
MUST-READ REVIEW
Gastrointestinal cancers in women: The role of sex hormones
by Amit Yadav &
Prof Usha Dutta @UshaPGIMER#WomenGI#GItwitter
https://t.co/SHkGUyFpl5
On the occasion of International Women's Day
We released the special issue of @IJG_Journal on women and gastroenterology.
It is purple to signify women empowerment
#GITwitter#WomensDayEveryDay
https://t.co/7tUEf2gS3e…
🧵3..Assessment of Shock Phenotypes and AKI phenotypes is the best strategy for management of the hepatocardiorenal axis.
POCUS is the simplest and safest tool in hepatology practice..🎯 @ajay_duseja@AnandVKulkarni2@drnipunverma@salvatore_piano
Point-of-care ultrasound (POCUS) guided pragmatic fluid and albumin resuscitation and hemodynamic monitoring in Cirrhosis and Septic Shock -🧵1 https://t.co/Di2fLAwvss
Comments Welcome! @RoyAHep@hepocus@KavishPatidar11@kumarrahul0204@ebtapper
🧵2 Restrictive and Effective POCUS guided volume resuscitation works best.
Shock is a spectrum...Phenotypes are between Fluid responsive to circulatory failure. ✅️⏳️Time based perfusion targets reduce mortality. Assessment of CCM and Fluid challenge ➡️ 'cardiac reserve'